Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000552454 | SCV000625715 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2024-04-07 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000583783 | SCV000691130 | likely benign | Hereditary cancer-predisposing syndrome | 2016-12-07 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003330749 | SCV004038296 | uncertain significance | not specified | 2023-08-07 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003478116 | SCV004219043 | uncertain significance | not provided | 2023-05-30 | criteria provided, single submitter | clinical testing | To the best of our knowledge, this variant has not been reported in the published literature. It also has not been reported in large, multi-ethnic general populations (Genome Aggregation Database, http://gnomad.broadinstitute.org). Analysis of this variant using software algorithms for the prediction of the effect of nucleotide changes on splicing yielded predictions that this variant does not affect PMS2 mRNA splicing . Based on the available information, we are unable to determine the clinical significance of this variant. |
All of Us Research Program, |
RCV004003770 | SCV004831762 | likely benign | Lynch syndrome | 2023-07-10 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003960248 | SCV004766827 | likely benign | PMS2-related disorder | 2023-05-04 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |